Missouri would restrict DEHP in IV containers and tubing

People and businesses could not sell or distribute IV solution containers made with intentionally added DEHP in Missouri. The rule covers containers used to hold medicine, fluid, or nutrition delivered through a vein in a health care facility. Blood collection and storage bags, and certain apheresis and cell therapy kits and bags with integral tubing, would be exempt. The deadline could move to January 1, 2032, for a person or business that meets all listed reasons and notice requirements.

People and businesses could not make, sell, or distribute IV tubing made with intentionally added DEHP. They also could not replace DEHP with another chemical in the ortho-phthalate class in a new or revised medical device. IV tubing means tubing used to deliver fluids, medication, or nutrients directly to an adult, child, or infant through a vein. Blood collection and storage bags, and certain apheresis and cell therapy kits and bags with integral tubing, would be exempt. The tubing restrictions would begin January 1, 2035.

IV solution containers and tubing products could not contain unintentionally added DEHP at or above 0.1 percent by weight. The limit applies to IV solution containers and IV tubing products. Unintentionally added DEHP means DEHP that does not have a functional or technical effect on the product. Blood collection and storage bags, and certain apheresis and cell therapy kits and bags with integral tubing, would be exempt.